Category: Uncategorized

New Biomarker Signature for COPD

Former BU innovator of the year– Professor and Chief of Computational Biomedicine in the Department of Medicine, Dr. Avi Spira, M.D, Ph.D., has come up with a new biomarker signature to improve the treatment of Chronic Obstructive Pulmonary Disease (COPD), which affects 14.8 million individuals in the United States, and is predicted to become the [...]

Treating IgE-Mediated Diseases with Modified Soluble CD23

Through her work with human schistosomiasis, Dr. Lisa Ganley-Leal has identified a compound that may have the ability to treat severe allergic diseases, such as a moderate to severe asthma. The new therapeutic holds the promise of improved efficacy for multiple allergic diseases combined with a lower risk of side effects. The current treatment for [...]

Message from the Director – The Year in Review

Dear Reader, We had an exciting 2011 at OTD with key accomplishments summarized below. The group is now complete and we are projecting 2012 to be very active, with several new ventures in the pipeline and many industry license discussions on-going. We have significant commercialization activity emerging from (1) Coulter Translational Partnership in the Biomedical [...]

Spotlight on: INTICA Biomedical

Getting a New Venture off the ground can prove a daunting task even for the most experienced entrepreneurs. To help these fledgling companies get up on their feet, the Office of Technology Development awards an outstanding company based on research from an entrepreneurial faculty member of Boston University with the Launch award. The award consists [...]

OTD Ignition Award Recipients for 2011

The Office of Technology Development’s Ignition Award is designed to help new technologies bridge the (funding?) gap between discovery-oriented research and subsequent development.  By providing funding that helps these fledgling technologies reach specific goals or milestones (to show proof of applicability), the Ignition Award helps further them on the path toward commercialization.  Each year, applicants [...]

New Ventures – Renuka Babu

As Boston University’s Director of New Ventures at the Office of Technology Development, my focus is to help build new companies based on technologies being created at the University. I was excited by the tremendous interest of faculty in participating in the creation of new ventures.  I’ve found our experienced researchers are keen on finding [...]

AngelHack Hackathon 2012

With up to $55,000 in prizes to give away, the angelHack Hackathon is a great opportunity for any Boston-area entrepreneurs looking to build a start-up.  Contestants come from all over the east coast to participate in the Hackathon, which kicks off on March 3rd with a networking event.  There, attendees can talk with other likeminded [...]

Message from the Director: MedTech and BU

Dear Reader, Boston University’s Graduate BioMedical Engineering (BME) department is ranked #8 by US News and World Report.1 In 2010-2011, BME’s 33 primary faculty members attracted $24.3 million in external research funding. Many BME faculty collaborate with clinicians and medical researchers at the BU School of Medicine. As an endorsement of this, BME was one [...]

AcuityBio wins $1.4M SBIR grant to develop drug-eluting ABC Mesh™ for lung cancer patients

Lung cancer is diagnosed in over 220,000 patients in the U.S. every year, and results in more cancer deaths than breast, colorectal, and prostate cancers combined.   If detected at an early-stage, lung cancer can be treated using standard of care surgery.   Most of these patients treated with surgery have reduced lung function and surgeons would [...]

Spotlight on the Wallace H. Coulter Translational Research Partnership at BU

The Wallace H. Coulter Foundation sponsors an annual program that provides gap funding to accelerate commercial development of medical technologies invented at the university.  “The Coulter program intends to bring ideas together from different parts of the university,” says Art Rosenthal (Professor of Practice at BU).  “We want to increase collaborations between biomedical engineers and [...]